Delay discounting using a sequential patch depletion procedure, water consumption rate during the last two sessions with an experimenter-imposed delay of 18 sec
Tags: Behavior · Delay discounting
Project: p50_david_dietz
1 loci · 1 genes with independent associations · 2 total associated genes
# | Chr | Start pos | End pos | # assoc genes | # joint models | Best TWAS P | Best GWAS P | Cond GWAS P | Joint genes |
---|---|---|---|---|---|---|---|---|---|
1 | 1 | 140614300 | 142727457 | 2 | 1 | 1.95e-10 | 3.55e-09 | 3.56e-01 | Grm5 |
Tissue | RNA modality | # hits | % hits/tests | Avg chisq |
---|---|---|---|---|
Adipose | alternative polyA | 0 | 0 | 1.3 |
Adipose | alternative TSS | 0 | 0 | 1.27 |
Adipose | gene expression | 0 | 0 | 1.31 |
Adipose | isoform ratio | 0 | 0 | 1.26 |
Adipose | intron excision ratio | 0 | 0 | 1.34 |
Adipose | mRNA stability | 0 | 0 | 1.31 |
BLA | alternative polyA | 2 | 0.2 | 1.39 |
BLA | alternative TSS | 0 | 0 | 1.33 |
BLA | gene expression | 1 | 0 | 1.33 |
BLA | isoform ratio | 0 | 0 | 1.27 |
BLA | intron excision ratio | 0 | 0 | 1.35 |
BLA | mRNA stability | 1 | 0 | 1.35 |
Brain | alternative polyA | 0 | 0 | 1.3 |
Brain | alternative TSS | 0 | 0 | 1.31 |
Brain | gene expression | 1 | 0 | 1.36 |
Brain | isoform ratio | 1 | 0 | 1.25 |
Brain | intron excision ratio | 0 | 0 | 1.38 |
Brain | mRNA stability | 0 | 0 | 1.33 |
Eye | alternative polyA | 0 | 0 | 1.02 |
Eye | alternative TSS | 0 | 0 | 1.05 |
Eye | gene expression | 1 | 0.1 | 1.24 |
Eye | isoform ratio | 0 | 0 | 1.24 |
Eye | intron excision ratio | 0 | 0 | 1.18 |
Eye | mRNA stability | 0 | 0 | 1.22 |
IL | alternative polyA | 0 | 0 | 1.45 |
IL | alternative TSS | 0 | 0 | 1.18 |
IL | gene expression | 1 | 0 | 1.33 |
IL | isoform ratio | 0 | 0 | 1.3 |
IL | intron excision ratio | 0 | 0 | 1.42 |
IL | mRNA stability | 0 | 0 | 1.35 |
LHb | alternative polyA | 0 | 0 | 1.27 |
LHb | alternative TSS | 0 | 0 | 1.38 |
LHb | gene expression | 0 | 0 | 1.36 |
LHb | isoform ratio | 0 | 0 | 1.42 |
LHb | intron excision ratio | 0 | 0 | 1.33 |
LHb | mRNA stability | 0 | 0 | 1.3 |
Liver | alternative polyA | 0 | 0 | 1.34 |
Liver | alternative TSS | 0 | 0 | 1.25 |
Liver | gene expression | 0 | 0 | 1.36 |
Liver | isoform ratio | 0 | 0 | 1.3 |
Liver | intron excision ratio | 0 | 0 | 1.28 |
Liver | mRNA stability | 0 | 0 | 1.29 |
NAcc | alternative polyA | 0 | 0 | 1.32 |
NAcc | alternative TSS | 0 | 0 | 1.35 |
NAcc | gene expression | 0 | 0 | 1.33 |
NAcc | isoform ratio | 0 | 0 | 1.34 |
NAcc | intron excision ratio | 0 | 0 | 1.34 |
NAcc | mRNA stability | 0 | 0 | 1.34 |
OFC | alternative polyA | 0 | 0 | 1.37 |
OFC | alternative TSS | 0 | 0 | 1.31 |
OFC | gene expression | 0 | 0 | 1.33 |
OFC | isoform ratio | 0 | 0 | 1.33 |
OFC | intron excision ratio | 0 | 0 | 1.28 |
OFC | mRNA stability | 0 | 0 | 1.35 |
PL | alternative polyA | 0 | 0 | 1.39 |
PL | alternative TSS | 0 | 0 | 1.37 |
PL | gene expression | 0 | 0 | 1.35 |
PL | isoform ratio | 0 | 0 | 1.35 |
PL | intron excision ratio | 0 | 0 | 1.29 |
PL | mRNA stability | 1 | 0 | 1.34 |